Misty Shields, Assistant professor of clinical medicine at Indiana University, shared on X:
“Incredibly honored to be a part of this important initiative with Lung Cancer Europe that highlights the current state of small cell lung cancer care and the challenges our SmallCellSMASHERS face. These include limited or no involvement in treatment decision making, few being offered clinical trials, and major gaps in available support.
Many patients access the internet for information that may be outdated or inaccurate for their own case. Dr. Google is simply not a good doctor. While we have seen such unprecedented progress in small cell lung cancer care, namely immunotherapy, T-cell engagers, lurbinectedin, and ADCs, breakthroughs in scientific advances only matter if people can actually reach them.
Read the full report ‘Many Faces, One Voice’.
‘Fast Diagnosis, Fragmented Support: Living with Small Cell Lung Cancer in Europe‘”
This also can be interesting:
DeLLphi-304 Trial: Tarlatamab Versus Chemotherapy in SCLC
